FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387481005: Sodium valproate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1481572018 Valproate sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492110013 Sodium dipropylacetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492111012 Sodium alpha-propylvalerate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492112017 DPA sodium en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2693321012 Sodium valproate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5170815016 Sodium valproate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4500221000005115 Valproatnatrium da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium valproate Is a Valproic acid (substance) false Inferred relationship Some
Sodium valproate Is a Valproat false Inferred relationship Some
Sodium valproate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Valproic acid (substance) true Inferred relationship Some
Sodium valproate Is a Valproate true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
forgiftning med valproatnatrium Causative agent False Sodium valproate Inferred relationship Some 1
accidentel forgiftning med valproatnatrium Causative agent False Sodium valproate Inferred relationship Some
tilsigtet forgiftning med valproatnatrium Causative agent False Sodium valproate Inferred relationship Some
forgiftning med valproatnatrium, uvist med hvilken hensigt Causative agent False Sodium valproate Inferred relationship Some 1
Sodium valproate adverse reaction Causative agent True Sodium valproate Inferred relationship Some 1
overdosis af natriumvalproat Causative agent False Sodium valproate Inferred relationship Some 1
accidentel overdosis af natriumvalproat Causative agent False Sodium valproate Inferred relationship Some 1
tilsigtet overdosis af natriumvalproat Causative agent False Sodium valproate Inferred relationship Some 1
overdosis af natriumvalproat, uvist med hvilken hensigt Causative agent False Sodium valproate Inferred relationship Some 1
natriumvalproat 400 mg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat til parenteral anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 500 mg pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 250 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
[X]Valproic acid causing adverse effects in therapeutic use Causative agent False Sodium valproate Inferred relationship Some
accidentel forgiftning med valproatnatrium Causative agent False Sodium valproate Inferred relationship Some 1
tilsigtet forgiftning med valproatnatrium Causative agent False Sodium valproate Inferred relationship Some 1
natriumvalproat tablet med modificeret udløsning til oral anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 100 mg tablet der kan knuses The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 200 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 300 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 500 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat til oral anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 200 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
natriumvalproat 200 mg/5 ml sukkerfri oral væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
Sodium valproate 200 mg gastro-resistant oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
Sodium valproate 500 mg gastro-resistant oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
Sodium valproate blood measurement Component False Sodium valproate Inferred relationship Some 2
Serum sodium valproate measurement Component False Sodium valproate Inferred relationship Some 2
Valproate sodium 100mg/mL solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
allergi over for natriumvalproat Causative agent False Sodium valproate Inferred relationship Some 2
Sodium valproate 100mg conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium valproate Inferred relationship Some
Sodium valproate 300 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 300 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 200 mg gastro-resistant oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 200 mg gastro-resistant oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 500 mg gastro-resistant oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 500 mg gastro-resistant oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 500 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 500 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 200 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 200 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 400 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 400 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 40 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 40 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
allergi over for natriumvalproat Causative agent False Sodium valproate Inferred relationship Some 1
Sodium valproate 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 100 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 100 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 2
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 2
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 2
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 2
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 2
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 2
Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 2
Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 2
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 2
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 2
Product containing precisely sodium valproate 1 gram/1 sachet prolonged-release oral granules (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 1 gram/1 sachet prolonged-release oral granules (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 300 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 300 milligram/1 each gastro-resistant oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 600 mg gastro-resistant oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 600 mg gastro-resistant oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 60 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 60 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 500 mg prolonged-release oral granules sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 500 mg prolonged-release oral granules sachet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Product containing precisely sodium valproate 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Sodium valproate 100 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium valproate Inferred relationship Some 1
Sodium valproate 100 mg/mL solution for infusion This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium valproate Inferred relationship Some 1
Serum sodium valproate measurement Component True Sodium valproate Inferred relationship Some 1
Sodium valproate blood measurement Component True Sodium valproate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start